These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 9388851)
1. [Effects of intermittent short-course chemotherapy under full-course supervision on the treatment of smear positive pulmonary tuberculosis]. Yan S; Ye H; Lin S Zhonghua Jie He He Hu Xi Za Zhi; 1996 Apr; 19(2):104-6. PubMed ID: 9388851 [TBL] [Abstract][Full Text] [Related]
2. [Long-term efficacy of full course intermittent short-course chemotherapy on new smear positive tuberculosis patients]. Zhonghua Jie He He Hu Xi Za Zhi; 1997 Jun; 20(3):164-6. PubMed ID: 10072822 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of short-term effects of short-course intermittent chemotherapies of the World Bank Loaned Project]. Wen S; Su Y; Zhang F Zhonghua Jie He He Hu Xi Za Zhi; 1996 Dec; 19(6):357-9. PubMed ID: 9596819 [TBL] [Abstract][Full Text] [Related]
4. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis]. Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720 [TBL] [Abstract][Full Text] [Related]
5. Assessment of a combined preparation of isoniazid, rifampicin and pyrazinamide (Rifater) in the initial phase of chemotherapy in three 6-month regimens for smear-positive pulmonary tuberculosis: a five-year follow-up report. Teo SK Int J Tuberc Lung Dis; 1999 Feb; 3(2):126-32. PubMed ID: 10091877 [TBL] [Abstract][Full Text] [Related]
6. [Follow-up observation on relapse of smear negative pulmonary tuberculosis after short-course chemotherapy]. Xu WG; Gao Z; Fan BD Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):74-6. PubMed ID: 12783655 [TBL] [Abstract][Full Text] [Related]
7. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related]
8. [A short course of chemotherapy in newly diagnosed and retreatment of smear-positive pulmonary tuberculosis in a rural area]. Zhonghua Jie He He Hu Xi Za Zhi; 1989 Aug; 12(4):220-2, 254-5. PubMed ID: 2636947 [TBL] [Abstract][Full Text] [Related]
9. [Efficacy of unfixed continuation phase short-course chemotherapy]. Xiao C; Fu Y; Li Z Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):358-60. PubMed ID: 10374447 [TBL] [Abstract][Full Text] [Related]
10. [The short-term and long-term treatment outcomes in patients with pulmonary tuberculosis positive for drug-resistant and sensitive strains]. Han JP; Sun SL; Li RZ; Zhang FS; Wang SC; Cheng J; Deng YF; Wang Y; Yu CB Zhonghua Jie He He Hu Xi Za Zhi; 2003 Feb; 26(2):70-3. PubMed ID: 12783654 [TBL] [Abstract][Full Text] [Related]
11. [The operational control studies of smear positive tuberculosis cases with short-course chemotherapy under the full-course management and supervision]. Dai YS; Li Q; Duanmu HJ Zhonghua Jie He He Hu Xi Za Zhi; 1994 Oct; 17(5):278-80, 318. PubMed ID: 7712567 [TBL] [Abstract][Full Text] [Related]
12. Fixed dose combination short course chemotherapy in the treatment of pulmonary tuberculosis. Wolde K; Lema E; Roscigno G; Abdi A Ethiop Med J; 1992 Apr; 30(2):63-8. PubMed ID: 1345030 [TBL] [Abstract][Full Text] [Related]
13. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients]. Wada M Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781 [TBL] [Abstract][Full Text] [Related]
14. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
15. [Efficacy of regimens containing INH, RFP with varied chemotherapy courses on retreated culture positive pneumoconio-tuberculosis]. Jiang W; Chen H; Gao J; Huaibei M Zhonghua Jie He He Hu Xi Za Zhi; 1998 Nov; 21(11):648-50. PubMed ID: 11477888 [TBL] [Abstract][Full Text] [Related]
16. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
17. The comparison of tuberculosis treatments: a short course therapy and the directly observed short course treatment (DOTS), East Java Province, Indonesia. Roosihermiatie B; Nishiyama M; Nakae K Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):85-8. PubMed ID: 11023071 [TBL] [Abstract][Full Text] [Related]
18. Short-course tuberculosis chemotherapy studies conducted in Poland during the past decade. Snider DE; Zierski M; Graczyk J; Bek E; Farer LS Eur J Respir Dis; 1986 Jan; 68(1):12-8. PubMed ID: 3512281 [TBL] [Abstract][Full Text] [Related]
19. [Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis]. Xu RX Zhonghua Jie He He Hu Xi Za Zhi; 1987 Oct; 10(5):261-3, 307. PubMed ID: 3131029 [No Abstract] [Full Text] [Related]
20. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis. Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]